Biocrates

Executive Summary

Biocrates is an Austrian life sciences company that specializes in standardized, ready-to-use kits and services for quantitative metabolomics analysis using mass spectrometry. Founded in 2002 and headquartered in Innsbruck, the company serves pharmaceutical, academic, and clinical research clients globally. Its mission is to make robust metabolomics accessible to accelerate biomedical research and personalized health insights. Biocrates has established itself as a leader in the metabolomics field by providing reproducible and reliable measurement of metabolites in biological samples, enabling customers to advance biomarker discovery, drug development, and clinical diagnostics. The company’s technology is widely adopted for its ease of use and high reproducibility, positioning it as a key enabler in the growing field of systems biology and precision medicine.

Upcoming Catalysts (preview)

• Q3 2026Launch of new high-throughput metabolomics kit for clinical research65% success
• Q2 2026Strategic partnership with a major pharmaceutical company for biomarker discovery70% success
• Q4 2026Achievement of IVDR certification for diagnostic application of a metabolomics panel55% success